MLchartDataset catalogue

MART-1:27-35 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015014

A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.

Table 1. Record
IdentifierMLC-T-ONC-015014
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015014",
  "term": "MART-1:27-35 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mart-1-27-35-peptide-vaccine/"
}

Record 10,648 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.